Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS in Children With ASD and Genetic Problems or PANDAS
NCT06368726Phase 2Completed
- Sponsor
- Spanish Foundation for Neurometrics Development
- Start
- Apr 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 2 trial in Autism Spectrum Disorder (ASD) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) (3 arms), sponsored by Spanish Foundation for Neurometrics Development. Primary endpoints: Fast Fourier Transform at 12 months, Power Density Spectrum Changes at 12 months and 1 more. Started Apr 2024; status: completed.
02
Conditions
Autism Spectrum Disorder (ASD)Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)
Beyond the preview
Go deeper on NCT06368726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06368726.